Jin Medical International (ZJYL) Receivables (2022 - 2026)

Jin Medical International has disclosed Receivables across 5 years of filings, most recently posting $20.3 million for Q1 2026.

• In Q1 2026, Receivables fell 100.0% year-over-year to $20.3 million; the TTM figure through Mar 2026 stood at $20.3 million (down 100.0% YoY), while the FY2025 annual figure was $20.2 million, down 100.0% from the prior year.
• Receivables came in at $20.3 million for Q1 2026 at Jin Medical International, roughly flat from $20.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $4376.3 billion in Q1 2025 to a low of $4.0 million in Q3 2022.
• Average Receivables over 5 years is $1567.3 billion, with a median of $20.3 million recorded in 2025.
• Year-over-year, Receivables soared 107021091.06% in 2023 and tumbled 100.0% in 2024.
• Over 5 years, Receivables stood at $4.0 million in 2022, then soared by 107021091.06% to $4240.5 billion in 2023, then plunged by 100.0% to $18.9 million in 2024, then increased by 7.01% to $20.2 million in 2025, then advanced by 0.21% to $20.3 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $20.3 million in Q1 2026, $20.2 million in Q3 2025, and $4376.3 billion in Q1 2025.